Do you have any queries?

or Call us now at 9982-782-555

back-arrow-image Search Health Packages, Tests & More
arrow image Back To Teams
Promoter and Managing Director Metropolis Healthcare Ltd

Ms. Ameera Shah

Ameera Shah is the Executive Chairperson and Whole-time Director of Metropolis Healthcare Limited. She has built Metropolis Healthcare into a leading corporate entity in India’s diagnostic sector, transforming it from a doctor-led practice into a prominent industry player. Over the past two decades, she has driven the Company’s remarkable growth and corporate evolution, including taking Metropolis public in 2019. Under her leadership, the Company attracted three rounds of investment from top private equity firms and consistently delivered industry-leading performance and strong returns for investors.

Ameera's achievements have been widely recognized. She received the Ernst & Young ‘Entrepreneur of the Year’ Award in healthcare for 2021. She is one of only three women to have received this award in the past 20 years and is the youngest woman ever to receive it. She has been named one of ‘Asia’s Power Businesswomen’ by Forbes Asia and included among the ‘Fifty Most Powerful Women in Business’ by Fortune India and Business Today. She has also been bestowed with multiple awards for her outstanding performance and excellence in the diagnostics business and entrepreneurship from various esteemed organizations.

Ameera holds a degree in Finance from The University of Texas at Austin and is an alumnus of the Harvard Business School (OPM Program). She is an eminent industry spokesperson and has spoken at various national and international forums, industry events, and conclaves. She has been an active member and has served in senior-level positions in key industry bodies that drive policy decisions at the Center. Currently, she serves as Sr. Vice-President of NATHealth (Healthcare Federation of India).

Ameera is also an Independent Director on the boards of Torrent Pharma and ACC Limited, which is part of the Adani Group. Prior to the pandemic, she was an advisor to Baylor College of Medicine, Texas, and the global advisory board of AXA, a Paris-headquartered company with $700 billion in assets under management.